{"date":"2025-06-24","count":15,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6762-2025-06-24-1941-1m9ssep","company_id":"6762","company":"達亞","market":"上櫃","industry":"生技醫療","date":"2025-06-24","time":"19:41:11","subject":"本公司董事長決定限制員工權利新股之增資基準日","clause":"第53款","fact_date":"2025-06-24","cite_as":"公開資訊觀測站重大訊息：達亞（6762），2025-06-24 19:41，「本公司董事長決定限制員工權利新股之增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6662-2025-06-24-1816-c6mjy7","company_id":"6662","company":"樂斯科","market":"上櫃","industry":"生技醫療","date":"2025-06-24","time":"18:16:30","subject":"公告本公司發言人及公司治理主管異動","clause":"第8款","fact_date":"2025-06-24","cite_as":"公開資訊觀測站重大訊息：樂斯科（6662），2025-06-24 18:16，「公告本公司發言人及公司治理主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7790-2025-06-24-1733-ppxtus","company_id":"7790","company":"思必瑞特","market":"興櫃","industry":"生技醫療","date":"2025-06-24","time":"17:33:36","subject":"公告本公司股東會通過資本公積轉增資發行新股修正案","clause":"第9款","fact_date":"2025-06-24","cite_as":"公開資訊觀測站重大訊息：思必瑞特（7790），2025-06-24 17:33，「公告本公司股東會通過資本公積轉增資發行新股修正案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7790-2025-06-24-1729-hiebb2","company_id":"7790","company":"思必瑞特","market":"興櫃","industry":"生技醫療","date":"2025-06-24","time":"17:29:23","subject":"公告本公司114年股東會重要決議事項","clause":"第15款","fact_date":"2025-06-24","cite_as":"公開資訊觀測站重大訊息：思必瑞特（7790），2025-06-24 17:29，「公告本公司114年股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2025-06-24-1715-f51b84","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2025-06-24","time":"17:15:30","subject":"公告本公司董事會決議通過營業部主管及研發部主管任命案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2025-06-24 17:15，「公告本公司董事會決議通過營業部主管及研發部主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2025-06-24-1706-17xa2dn","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2025-06-24","time":"17:06:58","subject":"公告本公司發行國內第三次無擔保轉換公司債，向金管會申請延長募集期間三個月，業經金管會准予備查","clause":"第51款","fact_date":"2025-06-24","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2025-06-24 17:06，「公告本公司發行國內第三次無擔保轉換公司債，向金管會申請延長募集期間三個月，業經金管會准予備查」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2025-06-24-1705-ds864w","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2025-06-24","time":"17:05:56","subject":"公告本公司114年股東常會重要決議事項","clause":"第15款","fact_date":"2025-06-24","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2025-06-24 17:05，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3176-2025-06-24-1644-qmpqzy","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2025-06-24","time":"16:44:13","subject":"開發中新藥OBP-301進度更新","clause":"第53款","fact_date":"2025-06-24","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2025-06-24 16:44，「開發中新藥OBP-301進度更新」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6814-2025-06-24-1544-mfo08x","company_id":"6814","company":"路迦生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-24","time":"15:44:11","subject":"公告本公司審計委員會之成員異動","clause":"第6款","fact_date":"2025-06-24","cite_as":"公開資訊觀測站重大訊息：路迦生醫（6814），2025-06-24 15:44，「公告本公司審計委員會之成員異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6814-2025-06-24-1542-1v5ecel","company_id":"6814","company":"路迦生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-24","time":"15:42:48","subject":"公告本公司114年股東常會補選獨立董事一席當選名單","clause":"第6款","fact_date":"2025-06-24","cite_as":"公開資訊觀測站重大訊息：路迦生醫（6814），2025-06-24 15:42，「公告本公司114年股東常會補選獨立董事一席當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6814-2025-06-24-1539-hiebb2","company_id":"6814","company":"路迦生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-24","time":"15:39:49","subject":"公告本公司114年股東會重要決議事項","clause":"第15款","fact_date":"2025-06-24","cite_as":"公開資訊觀測站重大訊息：路迦生醫（6814），2025-06-24 15:39，「公告本公司114年股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2025-06-24-1528-19v3bzp","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2025-06-24","time":"15:28:09","subject":"代重要子公司Belite Bio, Inc公告董事會決議通過香港子公司投資設立瑞士子公司","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2025-06-24 15:28，「代重要子公司Belite Bio, Inc公告董事會決議通過香港子公司投資設立瑞士子公司」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7829-2025-06-24-1503-1vjqj49","company_id":"7829","company":"思捷優達-KY","market":"興櫃","industry":"生技醫療","date":"2025-06-24","time":"15:03:28","subject":"公告本公司財務主管、會計主管及代理發言人異動","clause":"第11款","fact_date":"2025-06-24","cite_as":"公開資訊觀測站重大訊息：思捷優達-KY（7829），2025-06-24 15:03，「公告本公司財務主管、會計主管及代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6615-2025-06-24-1341-zxfqmi","company_id":"6615","company":"慧智","market":"上櫃","industry":"生技醫療","date":"2025-06-24","time":"13:41:04","subject":"慧智基因受邀參加福邦證券所舉辦之法人說明會","clause":"第12款","fact_date":"2025-06-25","cite_as":"公開資訊觀測站重大訊息：慧智（6615），2025-06-24 13:41，「慧智基因受邀參加福邦證券所舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6875-2025-06-24-0620-ty5nf5","company_id":"6875","company":"國邑*","market":"上櫃","industry":"生技醫療","date":"2025-06-24","time":"06:20:11","subject":"公告本公司開發中新藥L608獲歐盟委員會(European Commission)正式授予孤兒藥資格認定","clause":"第53款","fact_date":"2025-06-23","cite_as":"公開資訊觀測站重大訊息：國邑*（6875），2025-06-24 06:20，「公告本公司開發中新藥L608獲歐盟委員會(European Commission)正式授予孤兒藥資格認定」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}